Dabigatran prescribing information is updated
June 14th 2012Label prescribing information for dabigatran (Pradaxa, Boehringer Ingelheim) capsules has been updated to affirm that the 150-mg twice-daily dose is superior to warfarin in reducing ischemic and hemorrhagic strokes in patients with nonvalvular atrial fibrillation.
FDA approves pertuzumab for treatment of HER2-positive metastatic breast cancer
June 11th 2012FDA has approved pertuzumab (Perjeta, Roche) in combination with trastuzumab (Herceptin) and docetaxel chemotherapy for the treatment of people with HER2-positive metastatic breast cancer who have not received prior anti-HER2 therapy or chemotherapy for metastatic disease.
Digestive 3 in 1 Health liquid dietary supplement recalled for potential Salmonella contamination
June 8th 2012Botanical Laboratories Inc. is recalling 38 bottles of 33.8-oz. "Wellesse Digestive 3 in 1 Health" liquid dietary supplement and 275 bottles of 16-oz. liquid dietary supplement, after a supplier said one of the ingredients could be contaminated with Salmonella, which can be fatal in young children, frail and elderly people, and others with weakened immune systems.
U.S. House passes bill for purchase of OTC medications through FSAs, HSAs without prescription
June 8th 2012A bill has passed in the U.S. House of Representatives (H.R. 436, the "Protect Medical Innovation Act of 2012") that will allow consumers to purchase OTC medications through their flexible health spending accounts and health savings accounts without first obtaining a prescription.